ReviewLung cancer (Amsterdam, Netherlands)2024

Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer.

Motohiro Izumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.